<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Perioperative uses of intravenous opioids in adults: General considerations
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Perioperative uses of intravenous opioids in adults: General considerations
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Perioperative uses of intravenous opioids in adults: General considerations
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth Casserly, PharmD, BCPS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John C Alexander, MD, MBA
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Girish P Joshi, MB, BS, MD, FFARCSI
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1441566074">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intravenous (IV) opioids are commonly used to provide analgesia and supplement sedation during general anesthesia or monitored anesthesia care (MAC) and are the most widely used agents for treatment of acute pain in the immediate postoperative period.
        </p>
        <p>
         Opioids selected for perioperative use bind primarily to mu receptors in the central nervous system to produce excellent analgesia, as well as respiratory depression, miosis, and euphoria. Opioid binding to mu receptors in the peripheral nervous system produces additional effects such as cough suppression (bronchial receptors) and opioid-induced constipation (intestinal receptors). (See
         <a class="medical medical_review" href="/z/d/html/7804.html" rel="external">
          "Opioid use disorder: Epidemiology, clinical features, health consequences, screening, and assessment", section on 'Mechanism of action'
         </a>
         .)
        </p>
        <p>
         This topic will review perioperative uses, benefits, and adverse effects of IV opioid agents. Specific opioids used in the perioperative setting are reviewed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/130113.html" rel="external">
          "Perioperative uses of intravenous opioids: Specific agents"
         </a>
         .)
        </p>
        <p>
         Topics that review use of opioids in other settings (eg, critical care, palliative care, chronic pain management) are available elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2888.html" rel="external">
          "Pain control in the critically ill adult patient", section on 'Opioid analgesics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/93598.html" rel="external">
          "Use of opioids in the management of chronic non-cancer pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2754072954">
         <span class="h1">
          BENEFITS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following effects of IV opioid agents make them useful during the perioperative period:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Effective analgesia. Opioids remain invaluable in the treatment of moderate to severe perioperative pain, and are sometimes necessary in multimodal analgesic regimens [
         <a href="#rid1">
          1,2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">
          "Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Management of pain'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2888.html" rel="external">
          "Pain control in the critically ill adult patient", section on 'Multimodal analgesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Additive or synergistic effects occur with coadministration of anesthetic or adjuvant agents from other pharmacologic classes (eg, sedative-hypnotics such as
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , benzodiazepines, inhalation anesthetics), allowing dose reduction of these agents [
         <a href="#rid3">
          3-14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Attenuation of autonomic responses to noxious stimuli that would otherwise result in tachycardia and hypertension [
         <a href="#rid13">
          13,15-19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Suppression of the cough and gag reflex is a class effect of opioids that is useful during manipulation of the airway (eg, laryngoscopy, intubation, or fiberoptic bronchoscopy) [
         <a href="#rid20">
          20-22
         </a>
         ]. However, although
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         causes dose-dependent cough suppression [
         <a href="#rid20">
          20
         </a>
         ], fentanyl-induced cough is also a commonly observed phenomenon. This may be clinically relevant if increased intrathoracic, intracranial, or intraocular pressure during coughing could be clinically deleterious [
         <a href="#rid23">
          23
         </a>
         ]. Fentanyl-induced cough can be ameliorated or prevented by very slow fentanyl administration over &gt;30 seconds, or by co-administration of
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , NMDA-receptor antagonists, alpha-2 agonists, or beta-2 agonists [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reduction of pain caused by injection of IV sedative-hypnotics and other agents (eg,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         ,
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         ,
         <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">
          rocuronium
         </a>
         ). Optimal pain reduction is achieved by coadministering IV opioid with an IV local anesthetic [
         <a href="#rid25">
          25-28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4025963507">
         <span class="h1">
          PREVENTION AND MANAGEMENT OF ADVERSE OPIOID EFFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         IV opioids have potential adverse side effects that can generally be prevented or treated:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exacerbation of hypotensive effects of sedative-hypnotics (eg,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , inhalation agents) [
         <a href="#rid10">
          10-12
         </a>
         ]. Although an opioid is often used to reduce the necessary dose of a sedative-hypnotic anesthetic agent with the goal of avoiding hypotension, administration of both classes of agent at standard or high doses may actually exacerbate hypotension, particularly in a hemodynamically unstable patient.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory depression and/or apnea [
         <a href="#rid29">
          29
         </a>
         ]. Opioid-induced respiratory impairment occurs due to depression of the respiratory center in the brainstem, depression of consciousness, and depression of supraglottic airway muscle tone that may lead to upper airway obstruction [
         <a href="#rid30">
          30
         </a>
         ]. During the intraoperative period, this may be a disadvantage in a spontaneously breathing patient or may delay time to tracheal extubation. Also, respiratory depression may lead to pulmonary complications in the postoperative period [
         <a href="#rid31">
          31-36
         </a>
         ]. Thus, opioid doses are reduced if other agents that may cause respiratory depression are also administered. (See
         <a class="medical medical_review" href="/z/d/html/4401.html" rel="external">
          "Overview of the management of postoperative pulmonary complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If significant hypoventilation occurs in a spontaneously breathing patient during monitored anesthesia care (MAC) or in the post-anesthesia care unit (PACU) after opioid administration, initial treatment is frequent stimulation to encourage adequate ventilation. Occasionally it is necessary to employ temporary positive pressure ventilation or to titrate low doses of IV
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         (eg, initial dose 40 mcg, then titrated as necessary up to 400 mcg). Careful titration of these naloxone doses typically reverses opioid effects safely, while preserving some analgesia. Rarely, the sudden reversal of analgesia causes a sympathetic surge with resultant hypertension, tachycardia, myocardial ischemia, or flash pulmonary edema. (See
         <a class="medical medical_review" href="/z/d/html/300.html" rel="external">
          "Acute opioid intoxication in adults", section on 'Management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4401.html" rel="external">
          "Overview of the management of postoperative pulmonary complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Postoperative respiratory depression occurs frequently in high-risk patients, including those of older age and/or those with obesity, obstructive sleep apnea, renal impairment, pre-existing cardiopulmonary disease (eg, chronic heart failure), male gender, or opioid naivety [
         <a href="#rid37">
          37,38
         </a>
         ]. In one prospective observational trial in 1335 hospitalized patients, opioid-induced respiratory depression occurred in 46 percent [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased intracranial pressure if hypercarbia occurs due to hypoventilation. Thus, ventilation is carefully monitored when opioids are administered to a spontaneously breathing patient with a head injury [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bradycardia, which may be severe with high doses of opioids [
         <a href="#rid40">
          40-42
         </a>
         ]. Treatment with a beta-adrenergic agonist (eg,
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         5 to 10 mg) or anticholinergic agent (eg,
         <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">
          glycopyrrolate
         </a>
         in 0.2 mg increments up to a total dose of 1 mg, or small incremental doses of
         <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">
          atropine
         </a>
         0.2 mg) will typically restore adequate heart rate. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Other bradyarrhythmias'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chest wall and skeletal muscle rigidity, which may make ventilation difficult. Dose and speed of opioid injection affect the likelihood and severity of rigidity. This problem is most common with lipophilic opioids, such as
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         ,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         ,
         <a class="drug drug_general" data-topicid="9347" href="/z/d/drug information/9347.html" rel="external">
          alfentanil
         </a>
         , or
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         [
         <a href="#rid43">
          43-51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Rigidity is prevented or reversed by administration of a neuromuscular blocking agent (NMBA) as soon as the patient is unresponsive and mask ventilation has been successfully established. In spontaneously breathing patients, rigidity can be reversed with
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         [
         <a href="#rid43">
          43,44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Delayed postoperative emergence or delirium. Management of these problems is described separately. (See
         <a class="medical medical_review" href="/z/d/html/93871.html" rel="external">
          "Delayed emergence and emergence delirium in adults", section on 'Opioids'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/93871.html" rel="external">
          "Delayed emergence and emergence delirium in adults", section on 'Emergence delirium'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative nausea and vomiting, particularly with high doses of opioids administered for a prolonged duration [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Anesthetic factors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative pruritus [
         <a href="#rid53">
          53
         </a>
         ]. This is uncommon if an IV synthetic opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         ) is administered only during the intraoperative period [
         <a href="#rid54">
          54
         </a>
         ]. Treatment options include administration of an antihistamine; low doses of an opioid antagonist, such as
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         administered in 4 mcg increments or 0.25 to 2 mcg/kg per hour to achieve the desired effect or until the patient experiences an increase in pain; or
         <a class="drug drug_general" data-topicid="9676" href="/z/d/drug information/9676.html" rel="external">
          nalbuphine
         </a>
         administered in 1 mg increments to a total of 5 mg [
         <a href="#rid53">
          53,55,56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative urinary retention. Management is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">
          "Overview of post-anesthetic care for adult patients", section on 'Inability to void'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative ileus and constipation. Management is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8042.html" rel="external">
          "Postoperative ileus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Possible effects on cancer recurrence. The effects of opioids on cancer cell biology are variable and conflicting among various opioids, and in some cases have been shown to be protective. Further discussion is available in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/117029.html" rel="external">
          "Anesthesia and cancer recurrence", section on 'Opioids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Potential for development of acute tolerance or opioid-induced hyperalgesia (OIH). Acute tolerance is a phenomenon whereby administration of opioids has a diminishing effect over a short period of time [
         <a href="#rid57">
          57
         </a>
         ]. OIH is characterized by nociceptive sensitization, with greater sensitivity to painful stimuli [
         <a href="#rid57">
          57-60
         </a>
         ]. These phenomena may increase postoperative pain and opioid dose requirements. Acute tolerance and OIH have been most thoroughly described with prolonged use (eg, outpatients with chronic pain, critically ill patients) and higher doses of
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         [
         <a href="#rid61">
          61-65
         </a>
         ]. However, acute tolerance is possible with any opioid. Thus, use of multimodal, opioid-sparing techniques has become the standard of care to limit this issue and other opioid-related adverse effects [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Potential for diversion with abuse, misuse, and opioid-related death if perioperative use leads to postoperative outpatient opioid prescriptions [
         <a href="#rid65">
          65-67
         </a>
         ]. Proposed solutions include software applications developed to track perioperative use of controlled substances, reduce discrepancies, and prevent diversion, as well as improved patient engagement in opioid management after hospital discharge [
         <a href="#rid2">
          2,68
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Since opioid-related adverse events are dose-dependent, multimodal opioid-sparing strategies that reduce opioid requirements are desirable. For example, protocols for early recovery after surgery (ERAS) emphasize avoidance of nausea, constipation, and ileus by limiting opioid dosing [
         <a href="#rid69">
          69-73
         </a>
         ] (see
         <a class="local">
          'Dosing considerations'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">
          "Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)"
         </a>
         ). Perioperative alternatives include use of regional analgesia; nonopioid analgesics, such as
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         , nonsteroidal antiinflammatory drugs (NSAIDs), or cyclooxygenase (COX)-2 specific inhibitors; and adjuvant agents with analgesic properties (eg,
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         ,
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         ) [
         <a href="#rid74">
          74,75
         </a>
         ]. Although alpha-2 adrenergic receptor agonists such as
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         or
         <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">
          clonidine
         </a>
         have been shown to reduce opioid requirements [
         <a href="#rid76">
          76,77
         </a>
         ], their role in intraoperative period is limited by their significant adverse effects such as bradycardia and hypotension [
         <a href="#rid78">
          78,79
         </a>
         ]. Similarly, beta-adrenergic receptor antagonists such as
         <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">
          esmolol
         </a>
         have been shown to reduce opioid requirements [
         <a href="#rid80">
          80,81
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults", section on 'Use multimodal analgesia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2888.html" rel="external">
          "Pain control in the critically ill adult patient", section on 'Multimodal analgesia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H153801862">
         <span class="h1">
          DOSING CONSIDERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Doses of IV opioids are individualized to avoid overdosing. Initial dosing is based, in part, on ideal body weight. Then, doses are titrated during administration (eg, to produce the desired analgesic effect in an awake patient or to supplement other anesthetic agents during induction and/or maintenance of general anesthesia). Genetic variability accounts for considerable variation in an individual's response to the beneficial analgesic effects and the adverse effects of opioids [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         Doses of opioids are often reduced for older patients and those with impaired renal, hepatic, or pulmonary function. Dosing may need to be increased in the setting of tolerance. Additionally, higher doses of opioids are sometimes used in conjunction with lower doses of sedative-hypnotic agents for induction of anesthesia in patients with depressed myocardial function (though this may impair early extubation efforts). (See
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents", section on 'Dosing considerations'
         </a>
         .)
        </p>
        <p>
         Also, for patients participating in enhanced recovery after surgery (ERAS), protocols, we employ intraoperative and postoperative multimodal pain prophylaxis and management strategies that minimize perioperative opioid use. (See
         <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">
          "Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Opioids'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">
          "Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Management of pain'
         </a>
         .)
        </p>
        <p>
         In one large study, administration of high opioid doses during the intraoperative period (32 mg
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         equivalents [27 to 41 mg]) was associated with an increased risk of hospital readmission compared with low intraoperative doses (8 mg morphine equivalents [4 to 9 mg]; adjusted odds ratio [OR] 1.75, 95% CI 1.46-2.10; n = 40,000 ambulatory surgical patients), with a dose-response effect across opioid dosing quintiles [
         <a href="#rid83">
          83
         </a>
         ]. Most readmissions occurred within 48 hours of ambulatory surgery. Administration of high opioid doses during the postoperative period has been associated with greater length of hospital stay, overall cost of care, and in-hospital cardiopulmonary complications including arrest [
         <a href="#rid84">
          84-88
         </a>
         ].
        </p>
        <p>
         Furthermore, a 2020 meta-analysis that included mostly noncardiac surgical studies noted that patients who received "high-dose" opioid administration during the intraoperative period may actually increase pain scores in the postoperative period compared with those receiving "low-dose" opioid administration [
         <a href="#rid89">
          89
         </a>
         ]. Nevertheless, higher opioid doses are necessary to achieve the desired effect in some patients who have developed tolerance due to chronic opioid use, compared with those who are opioid naive. (See
         <a class="local">
          'Chronic opioid use'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/7804.html" rel="external">
          "Opioid use disorder: Epidemiology, clinical features, health consequences, screening, and assessment", section on 'Tolerance'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4049775867">
         <span class="h1">
          OPIOID-FREE AND OPIOID-SPARING ANESTHETIC TECHNIQUES
         </span>
         <span class="headingEndMark">
          —
         </span>
         In light of the known adverse effects of opioids in both the intraoperative and post-acute postoperative phases of care, there have been concerted efforts to reduce opioid exposure [
         <a href="#rid90">
          90
         </a>
         ]. Evidence supports the analgesic efficacy of such opioid-sparing anesthetic techniques [
         <a href="#rid74">
          74,91
         </a>
         ], although they are underutilized in clinical practice [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
         Growing concern that higher doses of perioperative opioids may contribute to persistent postoperative opioid use and greater risk of dependence, addiction, and overdose has led some clinicians to advocate for "opioid-free" anesthesia [
         <a href="#rid90">
          90,91
         </a>
         ], whereby multimodal nonopioid analgesic techniques including regional anesthetic techniques are used to reduce or completely eliminate intraoperative and postoperative opioid use [
         <a href="#rid14">
          14,93-95
         </a>
         ]. A review of 1,104,324 surgical cases performed in 10 hospitals noted decreased intraoperative opioid use (from 152 to 129 mcg/kg parenteral
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         equivalent) from 2012 to 2016 [
         <a href="#rid96">
          96
         </a>
         ]. However, the authors also noted substantial variability among institutions even after controlling for patient and surgical variables, which suggests that efforts to change intraoperative opioid use practices should be targeted at departmental or institutional levels. A 2019 systematic review of randomized trials investigating use of intraoperative opioid administration compared with other analgesic agents or placebo found that pain scores were equivalent in opioid-inclusive versus opioid-free groups, although the incidence of postoperative nausea and vomiting (PONV) was lower in the opioid-free group (risk ratio [RR] 0.78, 95% CI 0.61-0.97; 1304 patients, 23 trials) [
         <a href="#rid97">
          97
         </a>
         ]. A subsequently published study noted similar results [
         <a href="#rid98">
          98
         </a>
         ].
        </p>
        <p>
         However, controversy exists regarding whether opioid-free anesthesia is necessary, or even feasible, in most surgical cases [
         <a href="#rid99">
          99,100
         </a>
         ]. Aside from reducing PONV, there is a paucity of data to support use of opioid-free anesthetic techniques in attempts to alter short- or long-term postoperative outcomes [
         <a href="#rid97">
          97
         </a>
         ]. Specifically, the use of opioid-free anesthetic techniques has not been shown to reduce postoperative opioid prescribing [
         <a href="#rid65">
          65,73,100
         </a>
         ]. Furthermore, inadequate treatment of pain carries its own risks; thus, effective analgesia is a primary goal of the anesthesiologist [
         <a href="#rid100">
          100,101
         </a>
         ]. Since all analgesic agents have potential adverse effects and risks as well as benefits, alternatives for each selected analgesic medication are considered for the individual patient’s planned analgesic regimen [
         <a href="#rid100">
          100
         </a>
         ]. Studies of nonopioid agent administration to reduce opioid requirements include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dexmedetomidine
         </strong>
         – In one trial of opioid-free maintenance of general anesthesia in noncardiac surgical patients, a balanced technique using an inhaled volatile anesthetic (
         <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">
          desflurane
         </a>
         ) combined with intravenous (IV) infusions of nonopioid analgesic agents that included
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         , and
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         was compared with use of desflurane combined with IV infusions of ketamine, lidocaine and
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         (plus a bolus dose of
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         administered at the end of surgery) [
         <a href="#rid102">
          102
         </a>
         ]. The study was stopped prematurely, after enrollment of 156 patients in each group, because of five cases of severe bradycardia in patients receiving dexmedetomidine, as well as a higher incidence of postoperative hypoxemia in that group (relative risk 1.19. 95% CI 1.01-1.33). Although patients receiving intraoperative dexmedetomidine rather than remifentanil plus morphine had less postoperative nausea and vomiting (relative risk 0.64, 95% CI 0.45-0.90) and less morphine consumption (6 mg [0 to 17] versus 11 mg [5 to 21]), other outcomes including ileus, cognitive dysfunction, and measures of analgesia were similar in the two groups [
         <a href="#rid102">
          102
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Dexmedetomidine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ketamine
         </strong>
         – In a systematic review of 130 studies that included 4588 patients receiving
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         for a broad range of surgical procedures and 3753 controls, postoperative analgesic consumption and pain intensity were reduced by subanesthetic doses of ketamine without differences in adverse effects compared with controls [
         <a href="#rid103">
          103
         </a>
         ]. A randomized trial of the effects of adding a low-dose ketamine infusion for postoperative pain control after spine surgery noted lower opioid requirements and lower pain scores for the first three postoperative days [
         <a href="#rid104">
          104
         </a>
         ]. However, ketamine is generally avoided in patients with ischemic heart disease, systemic hypertension, or psychosis. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Ketamine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gabapentinoids
         </strong>
         – Off-label administration of perioperative gabapentinoid has been included in perioperative opioid-sparing protocols [
         <a href="#rid105">
          105
         </a>
         ]. Although some studies suggest that gabapentinoids may reduce perioperative pain and opioid consumption [
         <a href="#rid106">
          106,107
         </a>
         ], other studies suggest no clinically significant analgesic effect, no effect on prevention of postoperative chronic pain, and a greater risk of adverse events (sedation, dizziness, and visual disturbances) [
         <a href="#rid108">
          108
         </a>
         ]. Furthermore, a retrospective study that included nearly 14,000 patients undergoing a broad range of surgical procedures noted that preoperative gabapentinoid administration did not reduce risk for prolonged postoperative opioid use [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         In general, we agree with consensus statements and expert opinion noting that data are not sufficient to recommend patient-specific or procedure-specific nonopioid agents and/or strategies such as regional anesthesia techniques for major invasive surgical procedures in order to completely avoid intraoperative opioid use, or to theoretically prevent persistent postoperative opioid use or undesirable opioid-related long-term outcomes [
         <a href="#rid14">
          14,90,110,111
         </a>
         ]. The best practice is to utilize the lowest dose of opioid for the shortest period of time while providing adequate analgesia [
         <a href="#rid14">
          14,92,94,99,100,112
         </a>
         ]. However, if opioids are minimized or avoided in an individual patient, it remains essential to ensure that intraoperative and postoperative analgesic alternatives are effective [
         <a href="#rid99">
          99,100,112,113
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1495146211">
         <span class="h1">
          PERIOPERATIVE USES OF OPIOIDS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Opioids are commonly used in the perioperative period during general anesthesia or to supplement sedation and analgesia during regional anesthesia, as well as for treatment of acute pain in the postoperative period [
         <a href="#rid114">
          114
         </a>
         ]. Specific uses, dosing, advantages, disadvantages, drug-drug interactions, and pharmacokinetics for opioids used during the perioperative period differ for each agent (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         ,
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         ,
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         ,
         <a class="drug drug_general" data-topicid="9347" href="/z/d/drug information/9347.html" rel="external">
          alfentanil
         </a>
         ,
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         ,
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9623" href="/z/d/drug information/9623.html" rel="external">
          methadone
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/130113.html" rel="external">
          "Perioperative uses of intravenous opioids: Specific agents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3970381375">
         <span class="h2">
          General anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         IV opioids may be used during the induction, maintenance, or emergence phases of general anesthesia, during monitored anesthesia care (MAC), and to treat pain in the immediate postoperative period. Selection of opioid agents and dosing considerations depend on the specific use, desired speed of onset and offset, procedure-specific factors (eg, degree of analgesia required, planned duration of surgery), patient-specific factors (eg, age, comorbidities, tolerance to opioids), and whether other anesthetics or adjuvant agents are coadministered. (See
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents", section on 'Opioids'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Analgesic component: Opioid agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H722402749">
         <span class="h3">
          Preinduction
         </span>
         <span class="headingEndMark">
          —
         </span>
         An opioid (eg, IV
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         25 to 50 mcg) may be employed as a sole or adjuvant preinduction agent for patients who complain of pain in the immediate preoperative period or for those undergoing a regional anesthetic procedure in the preinduction period.
        </p>
        <p class="headingAnchor" id="H2978013286">
         <span class="h3">
          Induction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Opioids are the most commonly used adjuvant agents during induction of general anesthesia.
        </p>
        <p class="headingAnchor" id="H1224100467">
         <span class="h4">
          Opioid use as an adjuvant agent
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typical doses of adjuvant opioid agents used during induction of anesthesia are noted in the table  (
         <a class="graphic graphic_table graphicRef111779" href="/z/d/graphic/111779.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         During laryngoscopy and endotracheal intubation, administration of an opioid is particularly useful for suppressing airway reflexes that result in coughing and/or bronchospasm [
         <a href="#rid20">
          20-22
         </a>
         ], as well as blunting sympathetic nervous system responses that would otherwise result in tachycardia and hypertension [
         <a href="#rid13">
          13,15-19
         </a>
         ]. Paradoxically,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         may induce transient coughing. This can be ameliorated or prevented by very slow fentanyl administration over &gt;30 seconds, or by co-administration of
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , NMDA-receptor antagonists, alpha-2 agonists, or beta-2 agonists [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Opioid administration also reduces dose requirements for the selected sedative-hypnotic induction agent [
         <a href="#rid6">
          6
         </a>
         ]. Furthermore, opioid coadministration with a local anesthetic during induction minimizes pain caused by injection of other agents (eg,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         ,
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         , or neuromuscular blocking agents) [
         <a href="#rid25">
          25-27,115,116
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1812591377">
         <span class="h4">
          High-dose opioid induction technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         In selected patients with poor myocardial function who will remain intubated with controlled ventilation for several postoperative hours after major surgery, some clinicians use a high-dose opioid technique for induction of general anesthesia (ie, "cardiac induction"). Typically,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         10 to 25 mcg/kg or
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         1 to 3 mcg/kg is used for this technique. Administration of a large opioid dose to induce anesthesia results in minimal direct myocardial depression and only a small decrease in arterial blood pressure, while minimizing tachycardia and/or hypertension during laryngoscopy and endotracheal intubation. However, a large opioid dose delays extubation, and may cause bradycardia and chest wall rigidity if administered as a bolus. (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Higher-dose opioid technique'
         </a>
         and
         <a class="local">
          'Prevention and management of adverse opioid effects'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H516346400">
         <span class="h4">
          Remifentanil intubation technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intubation techniques that include
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         , typically administration of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         2 to 2.5 mg/kg followed by remifentanil 3 to 5 mcg/kg, have been described for rapid sequence intubation (eg, when
         <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">
          succinylcholine
         </a>
         is contraindicated and the prolonged duration of a nondepolarizing neuromuscular blocking agent is undesirable). (See
         <a class="medical medical_review" href="/z/d/html/94214.html" rel="external">
          "Rapid sequence induction and intubation (RSII) for anesthesia", section on 'Remifentanil intubation'
         </a>
         .)
        </p>
        <p>
         For this intubation technique, a high dose of
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         (typically 3 to 5 mcg/kg) is administered as an IV bolus after administration of an induction dose of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         .
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          Ephedrine
         </a>
         10 mg IV is also administered to avoid bradycardia and hypotension that would otherwise result from a high dose of remifentanil combined with propofol (see
         <a class="local">
          'Prevention and management of adverse opioid effects'
         </a>
         above). This combination of agents typically provides good intubating conditions within 1 to 2.5 minutes while blunting the cough reflex and hemodynamic responses (eg, increased heart rate and blood pressure) [
         <a href="#rid117">
          117-119
         </a>
         ]. A remifentanil intubation technique is also used by some clinicians for awake fiberoptic intubation [
         <a href="#rid21">
          21,22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/139631.html" rel="external">
          "Awake tracheal intubation", section on 'Choice and administration of agent'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2897922683">
         <span class="h3">
          Maintenance
         </span>
         <span class="headingEndMark">
          —
         </span>
         During the maintenance phase of general anesthesia, an IV opioid is often employed as an adjuvant agent during an inhalation anesthetic technique. Opioids reduce the dose requirement for an inhalation anesthetic (ie, they reduce the minimum alveolar concentration [MAC] of an inhaled agent in the alveoli that is required to prevent movement in response to a surgical stimulus in 50 percent of patients). (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Dosing considerations'
         </a>
         .)
        </p>
        <p>
         An opioid is also commonly selected to provide the analgesic component of a total intravenous anesthesia (TIVA) technique, but none is sufficient to produce anesthesia if administered as a sole agent because opioids do not have a hypnotic effect. The addition of an opioid to a TIVA technique allows reduction of the required dose of the selected hypnotic agent, thereby hastening recovery at the end of the procedure. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Analgesic component: Opioid agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3912015127">
         <span class="h3">
          Emergence
         </span>
        </p>
        <p class="headingAnchor" id="H563375517">
         <span class="h4">
          Opioid use as an adjuvant agent
         </span>
         <span class="headingEndMark">
          —
         </span>
         During emergence from general anesthesia, administration of a small dose of IV opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         25 to 50 mcg) is often employed to attenuate coughing and/or bronchospasm resulting from reflex airway responses to the endotracheal tube or laryngeal mask airway.
        </p>
        <p class="headingAnchor" id="H1022975106">
         <span class="h4">
          Remifentanil extubation technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         In selected cases, it is desirable to avoid all coughing or retching during extubation (eg, when there is patient risk with any increase in intracranial pressure or intraocular pressure). In such cases, an infusion of
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         ≥0.1 mcg/kg per minute may be briefly administered, with tracheal extubation as soon as the patient can follow commands, which typically occurs before spontaneous respiratory efforts or recovery of airway reflexes. (See
         <a class="medical medical_review" href="/z/d/html/94224.html" rel="external">
          "Extubation following anesthesia", section on 'Minimizing physiologic response to extubation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96505.html" rel="external">
          "Anesthesia for emergency eye surgery", section on 'Emergence from anesthesia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3696324081">
         <span class="h2">
          Monitored anesthesia care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Opioids are often administered during sedation with monitored anesthesia care (MAC) to provide analgesia during placement of a regional anesthetic block, alleviate discomfort due to uncomfortable positioning, or supplement a regional block during incision and subsequent surgical stimulation. Opioids with rapid onset and short duration of action (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         ) are generally preferred. Oversedation with consequent respiratory depression is avoided [
         <a href="#rid30">
          30
         </a>
         ]. Opioid choices and dosing for MAC procedures and patient- and procedure-specific indications are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94529.html" rel="external">
          "Monitored anesthesia care in adults", section on 'Opioids'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H177868102">
         <span class="h2">
          Treatment of acute postoperative pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         IV opioids are widely used as a component of multimodal therapy to treat postoperative pain because of their ability to provide swift and potent analgesia. Opioid choices, dosing, indications, and cautions in the immediate postoperative period are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/134254.html" rel="external">
          "Use of opioids for postoperative pain control"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3120550018">
         <span class="h1">
          SPECIAL POPULATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2636519459">
         <span class="h2">
          Chronic opioid use
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who use opioids chronically may develop tolerance, withdrawal symptoms, and/or opioid-induced hyperalgesia with consequent use of higher opioid doses and/or alternative agents or techniques to provide analgesia in the perioperative period [
         <a href="#rid65">
          65
         </a>
         ]. In a retrospective analysis of over 16 million patients undergoing major surgical procedures, almost 95,000 had a diagnosis of opioid dependence or abuse (0.6 percent) [
         <a href="#rid120">
          120
         </a>
         ]. These patients had longer lengths of stay in the hospital and higher readmission rates than those without any history of opioid misuse. Attempts to mitigate these outcomes have led to efforts to reduce preoperative opioid use in chronic opioid users. One analysis of more than 57,000 chronic opioid users noted that changes (increases or decreases) to the preoperative opioid regimen were not associated with clinically significant differences for several postoperative outcomes including postoperative opioid use [
         <a href="#rid121">
          121
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7804.html" rel="external">
          "Opioid use disorder: Epidemiology, clinical features, health consequences, screening, and assessment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tolerance
         </strong>
         –
         <strong>
         </strong>
         Patients who have received prolonged or high daily opioid doses typically develop tolerance, a phenomenon whereby administration of opioids has a diminishing effect over time. This can usually be overcome with higher doses of opioids, although the risk of opioid-related adverse effects is increased with this strategy [
         <a href="#rid122">
          122-124
         </a>
         ]. Thus, perioperative use of multimodal, opioid-sparing techniques have become the standard of care. Options include use of continuous neuraxial or peripheral regional analgesia techniques, nonopioid analgesics such as
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         , nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase (COX)-2 specific inhibitors, gabapentinoids, and/or adjuvant inhalation or IV agents with analgesic properties (eg,
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         ,
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">
          clonidine
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults", section on 'Creating a plan for analgesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For tolerant patients who are chronically receiving
         <a class="drug drug_general" data-topicid="9623" href="/z/d/drug information/9623.html" rel="external">
          methadone
         </a>
         or
         <a class="drug drug_general" data-topicid="9170" href="/z/d/drug information/9170.html" rel="external">
          buprenorphine
         </a>
         , management of acute pain is discussed separately [
         <a href="#rid65">
          65,122-125
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/83726.html" rel="external">
          "Management of acute pain in the patient chronically using opioids for non-cancer pain"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/121628.html" rel="external">
          "Management of acute pain in adults with opioid use disorder"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Withdrawal symptoms
         </strong>
         – Acute opioid withdrawal may occur when opioids are abruptly discontinued, particularly if high daily doses have been administered over a prolonged period. Classic symptoms due to rebound increases in neurotransmitter release may be exacerbated by inadequate relief of surgical pain. These include sweating, lacrimation, tachycardia, and hypertension (as well as anxiety, nausea, and vomiting in an awake patient)  (
         <a class="graphic graphic_table graphicRef81045" href="/z/d/graphic/81045.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid122">
          122,126
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/306.html" rel="external">
          "Opioid withdrawal in the emergency setting", section on 'Clinical features of opioid withdrawal'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Opioid withdrawal symptoms are assessed with validated scale such as the Clinical Opiate Withdrawal Scale (COWS) in the perioperative period  (
         <a class="graphic graphic_table graphicRef106994" href="/z/d/graphic/106994.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid127">
          127,128
         </a>
         ]. As with opioid-tolerant patients, multi-modal analgesia techniques are used whenever feasible to maximize analgesia and minimize opioid-related adverse effects. In addition, an alpha
         <sub>
          2
         </sub>
         agonist, typically
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         , may be administered to reduce the undesirable physiologic effects of opioid withdrawal [
         <a href="#rid38">
          38,122,129
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1606.html" rel="external">
          "Sedative-analgesia in ventilated adults: Management strategies, agent selection, monitoring, and withdrawal", section on 'Discontinuation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/306.html" rel="external">
          "Opioid withdrawal in the emergency setting", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Opioid-induced hyperalgesia
         </strong>
         – Opioid-induced hyperalgesia (OIH) is a condition that may develop in patients chronically exposed to opioids. OIH is caused by nociceptive sensitization and is characterized by greater than expected sensitivity to painful stimuli and/or a paradoxical hyperalgesic response when an opioid is administered [
         <a href="#rid58">
          58,60
         </a>
         ]. Thus, nonopioid techniques and agents are employed to provide adequate perioperative analgesia when possible, similar to management of opioid tolerance. (See
         <a class="medical medical_review" href="/z/d/html/2800.html" rel="external">
          "Prevention and management of side effects in patients receiving opioids for chronic pain", section on 'Opioid-induced hyperalgesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Central sleep apnea
         </strong>
         – The pathophysiology of opioid-induced central sleep apnea in patients who use opioids chronically is based on dysfunction in respiratory rhythm generation and ventilatory chemoreflexes [
         <a href="#rid130">
          130
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4092558044">
         <span class="h2">
          Acute opioid intoxication
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with acute opioid intoxication may require emergency surgery (eg, after trauma). These patients have increased risk for opioid adverse effects. For example, acutely intoxicated patients may develop respiratory depression if the opioid of abuse has not been eliminated from the patient's system, particularly if additional opioids are administered during the perioperative period. Thus, it is helpful to determine the opioid agent, likely dose, and time of most recent administration to estimate duration of effect, and to consider whether other intoxicant agents may have been ingested. (See
         <a class="medical medical_review" href="/z/d/html/139188.html" rel="external">
          "Anesthesia for patients with substance use disorder or acute intoxication", section on 'Opioids'
         </a>
         .)
        </p>
        <p>
         Since such patients may have used opioids chronically, the clinician should be aware of the potential for development of tolerance with associated challenges for later control of postoperative pain [
         <a href="#rid122">
          122,123
         </a>
         ]. As noted above, perioperative analgesic management with nonopioid techniques and agents is employed when possible. (See
         <a class="local">
          'Chronic opioid use'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H958534491">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113643.html" rel="external">
          "Society guideline links: Opioid use disorder and withdrawal"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118304.html" rel="external">
          "Society guideline links: Acute pain management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2730096515">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Benefits
         </strong>
         –
         <strong>
         </strong>
         Benefits of perioperative use of intravenous (IV) opioids include effective analgesia, reduced requirements for other IV and inhalation anesthetic agents, attenuation of autonomic responses to noxious stimuli, and blunting of cough and gag reflexes during airway manipulation. (See
         <a class="local">
          'Benefits'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adverse effects
         </strong>
         –
         <strong>
         </strong>
         Potential adverse effects of opioids include exacerbation of hypotensive effects of other anesthetic agents (eg,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , inhalation anesthetics), respiratory depression and/or apnea, increased intracranial pressure (if hypoventilation results in hypercarbia), bradycardia, chest wall and skeletal muscle rigidity, postoperative delayed emergence, nausea and vomiting, pruritus, urinary retention, and potential for acute tolerance and opioid-induced hyperalgesia. (See
         <a class="local">
          'Prevention and management of adverse opioid effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perioperative uses of opioids
         </strong>
         –
         <strong>
         </strong>
         (
         <a class="graphic graphic_table graphicRef111779" href="/z/d/graphic/111779.html" rel="external">
          table 1
         </a>
         ) (See
         <a class="local">
          'Perioperative uses of opioids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Provision of analgesia for general anesthesia
         <strong>
          –
         </strong>
         We typically employ a short-acting opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         ) for bolus dosing during the preinduction, induction, maintenance, and/or emergence phases of general anesthesia.
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          Remifentanil
         </a>
         is most suitable for continuous infusion during a total intravenous anesthesia (TIVA) technique, particularly when the intensity of surgical stimulation will vary during the procedure. (See
         <a class="local">
          'General anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Provision of analgesia and supplemental sedation during monitored anesthesia care (MAC)
         <strong>
          –
         </strong>
         We typically employ a short-acting opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         ) for bolus dosing during MAC. (See
         <a class="local">
          'Monitored anesthesia care'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Treatment of postoperative pain  (
         <a class="graphic graphic_table graphicRef111779" href="/z/d/graphic/111779.html" rel="external">
          table 1
         </a>
         ) –
         <strong>
         </strong>
         For postoperative analgesia, we typically administer a long-acting opioid (eg,
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         or
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         ) approximately 20 to 30 minutes before anticipated tracheal extubation, with dose reduction if non-opioid analgesic agents or techniques are coadministered. (See
         <a class="local">
          'Treatment of acute postoperative pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dosing considerations
         </strong>
         –
         <strong>
         </strong>
         Doses of opioids are based on ideal body weight and are titrated to the desired analgesic effect  (
         <a class="graphic graphic_table graphicRef111779" href="/z/d/graphic/111779.html" rel="external">
          table 1
         </a>
         ). Doses are reduced with coadministration of anesthetic agents from other pharmacologic classes, older age or impaired renal or hepatic function, or hemodynamic abnormalities due to hypovolemia, vasodilation, or myocardial dysfunction. (See
         <a class="local">
          'Dosing considerations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perioperative alternatives to opioids
         </strong>
         –
         <strong>
         </strong>
         In general, we agree with consensus statements and expert opinion noting that data are not sufficient to recommend patient-specific or procedure-specific strategies to completely avoid intraoperative opioid use in order to theoretically prevent persistent postoperative opioid use or undesirable opioid-related long-term outcomes. We use the lowest dose of opioid for the shortest period of time while providing adequate analgesia. If opioids are minimized or avoided in an individual patient, it remains essential to ensure that intraoperative and postoperative analgesic alternatives are effective. (See
         <a class="local">
          'Opioid-free and opioid-sparing anesthetic techniques'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Special populations
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Chronic opioid use
         </strong>
         –
         <strong>
         </strong>
         Patients who use opioids chronically may develop tolerance, withdrawal symptoms  (
         <a class="graphic graphic_table graphicRef81045" href="/z/d/graphic/81045.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef106994" href="/z/d/graphic/106994.html" rel="external">
          table 3
         </a>
         ), and/or opioid-induced hyperalgesia, which may necessitate use of higher opioid doses or alternative agents or techniques to provide analgesia in the perioperative period. (See
         <a class="local">
          'Chronic opioid use'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute opioid intoxication
         </strong>
         –
         <strong>
         </strong>
         Patients with acute opioid intoxication may have increased risk for opioid adverse effects and opioid tolerance, as well as difficulties with control of postoperative pain. Perioperative analgesic management with nonopioid techniques and agents is employed when possible. (See
         <a class="local">
          'Acute opioid intoxication'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shishido S, Bowdle A. Rational Perioperative Opioid Management in the Era of the Opioid Crisis: Comment. Anesthesiology 2020; 133:941.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manyam SC, Gupta DK, Johnson KB, et al. Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes. Anesthesiology 2006; 105:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendrickx JF, Eger EI 2nd, Sonner JM, Shafer SL. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth Analg 2008; 107:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kazama T, Ikeda K, Morita K. The pharmacodynamic interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, and abdominal wall retraction. Anesthesiology 1998; 89:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81:820.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Short TG, Plummer JL, Chui PT. Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br J Anaesth 1992; 69:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kazama T, Ikeda K, Morita K. Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology 1997; 87:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Aken H, Meinshausen E, Prien T, et al. The influence of fentanyl and tracheal intubation on the hemodynamic effects of anesthesia induction with propofol/N2O in humans. Anesthesiology 1988; 68:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lang E, Kapila A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996; 85:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glass PS, Gan TJ, Howell S, Ginsberg B. Drug interactions: volatile anesthetics and opioids. J Clin Anesth 1997; 9:18S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mertens MJ, Olofsen E, Engbers FH, et al. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology 2003; 99:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung KS, Sinatra RS, Halevy JD, et al. A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction. Can J Anaesth 1992; 39:774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Egan TD. Are opioids indispensable for general anaesthesia? Br J Anaesth 2019; 122:e127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cork RC, Weiss JL, Hameroff SR, Bentley J. Fentanyl preloading for rapid-sequence induction of anesthesia. Anesth Analg 1984; 63:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pouraghaei M, Moharamzadeh P, Soleimanpour H, et al. Comparison between the effects of alfentanil, fentanyl and sufentanil on hemodynamic indices during rapid sequence intubation in the emergency department. Anesth Pain Med 2014; 4:e14618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casati A, Fanelli G, Albertin A, et al. Small doses of remifentanil or sufentanil for blunting cardiovascular changes induced by tracheal intubation: a double-blind comparison. Eur J Anaesthesiol 2001; 18:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Hare R, McAtamney D, Mirakhur RK, et al. Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth 1999; 82:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dahlgren N, Messeter K. Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia 1981; 36:1022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelly HE, Shaw GM, Brett CN, et al. The effect of titrated fentanyl on suppressed cough reflex in healthy adult volunteers. Anaesthesia 2016; 71:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnston KD, Rai MR. Conscious sedation for awake fibreoptic intubation: a review of the literature. Can J Anaesth 2013; 60:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang X, He W, Wu X, et al. TCI remifentanil vs. TCI propofol for awake fiber-optic intubation with limited topical anesthesia. Int J Clin Pharmacol Ther 2012; 50:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uvelin A, Rakic G. Guidelines for prevention of fentanyl-induced cough. Acta Anaesthesiol Scand 2009; 53:1228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JE, Min SK, Chae YJ, et al. Pharmacological and nonpharmacological prevention of fentanyl-induced cough: a meta-analysis. J Anesth 2014; 28:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Radaideh KM. [Effect of pretreatment with lidocaine, intravenous paracetamol and lidocaine-fentanyl on propofol injection pain. Comparative study. Rev Bras Anestesiol 2007; 57:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aouad MT, Siddik-Sayyid SM, Al-Alami AA, Baraka AS. Multimodal analgesia to prevent propofol-induced pain: pretreatment with remifentanil and lidocaine versus remifentanil or lidocaine alone. Anesth Analg 2007; 104:1540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahman Al-Refai A, Al-Mujadi H, Petrova Ivanova M, et al. Prevention of pain on injection of propofol: a comparison of remifentanil with alfentanil in children. Minerva Anestesiol 2007; 73:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi YJ, Park HS, Lee H, Yoon SZ. Single pretreatment of remifentanil may reduce pain after propofol and rocuronium injection in rapid sequence induction. Korean J Anesthesiol 2012; 63:413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Algera MH, Kamp J, van der Schrier R, et al. Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal. Br J Anaesth 2019; 122:e168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowen J, Levy N, Macintyre P. Opioid-induced ventilatory impairment: current 'track and trigger' tools need to be updated. Anaesthesia 2020; 75:1574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shapiro A, Zohar E, Zaslansky R, et al. The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine. J Clin Anesth 2005; 17:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cashman JN, Dolin SJ. Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data. Br J Anaesth 2004; 93:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Overdyk FJ, Carter R, Maddox RR, et al. Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia. Anesth Analg 2007; 105:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun Z, Sessler DI, Dalton JE, et al. Postoperative Hypoxemia Is Common and Persistent: A Prospective Blinded Observational Study. Anesth Analg 2015; 121:709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belcher AW, Khanna AK, Leung S, et al. Long-Acting Patient-Controlled Opioids Are Not Associated With More Postoperative Hypoxemia Than Short-Acting Patient-Controlled Opioids After Noncardiac Surgery: A Cohort Analysis. Anesth Analg 2016; 123:1471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prielipp RC, Fulesdi B, Brull SJ. Postoperative Opioid-Induced Respiratory Depression: 3 Steps Forward. Anesth Analg 2020; 131:1007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khanna AK, Bergese SD, Jungquist CR, et al. Prediction of Opioid-Induced Respiratory Depression on Inpatient Wards Using Continuous Capnography and Oximetry: An International Prospective, Observational Trial. Anesth Analg 2020; 131:1012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Honey BL, Benefield RJ, Miller JL, Johnson PN. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother 2009; 43:1506.
          </a>
         </li>
         <li class="breakAll">
          Stoelting R, Miller RD. Opioids. In: Basics of Anesthesia, 5th ed, Elsevier, Philadelphia 2007.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu W, Bidwai AV, Stanley TH, Isern-Amaral J. Cardiovascular dynamics after large doses of fentanyl and fentanyl plus N2O in the dog. Anesth Analg 1976; 55:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prakash O, Verdouw PD, de Jong JW, et al. Haemodynamic and biochemical variables after induction of anaesthesia with fentanyl and nitrous oxide in patients undergoing coronary artery by-pass surgery. Can Anaesth Soc J 1980; 27:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeSouza G, Lewis MC, TerRiet MF. Severe bradycardia after remifentanil. Anesthesiology 1997; 87:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coruh B, Tonelli MR, Park DR. Fentanyl-induced chest wall rigidity. Chest 2013; 143:1145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gravlee GP, Ramsey FM, Roy RC, et al. Rapid administration of a narcotic and neuromuscular blocker: a hemodynamic comparison of fentanyl, sufentanil, pancuronium, and vecuronium. Anesth Analg 1988; 67:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Afshan G. Are we anesthesiologists, aware about the incidence of muscle stiffness associated with remifentanil? Anesth Pain Med 2012; 1:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Honda T, Takenami T, Itou N, et al. [Increased dose of remifentanil caused difficult ventilation at emergence from general anesthesia]. Masui 2009; 58:980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kashimoto S, Iijma T, Amemiya M. [Case of muscle rigidity by remifentanil just before the end of surgery]. Masui 2009; 58:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao YJ, Liu S, Mao QX, et al. Efficacy and safety of remifentanil and sulfentanyl in painless gastroscopic examination: a prospective study. Surg Laparosc Endosc Percutan Tech 2015; 25:e57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dimitriou V, Zogogiannis I, Liotiri D, et al. Impossible mask ventilation after an unusually low dose fentanyl-induced muscle rigidity in a patient with essential tremor: a case report and review of the literature. Middle East J Anaesthesiol 2014; 22:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roy S, Fortier LP. Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine. Can J Anaesth 2003; 50:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buxton JA, Gauthier T, Kinshella MW, Godwin J. A 52-year-old man with fentanyl-induced muscle rigidity. CMAJ 2018; 190:E539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen E, Lim G, Ross SE. Evaluation of Therapies for Peripheral and Neuraxial Opioid-induced Pruritus based on Molecular and Cellular Discoveries. Anesthesiology 2021; 135:350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waxler B, Dadabhoy ZP, Stojiljkovic L, Rabito SF. Primer of postoperative pruritus for anesthesiologists. Anesthesiology 2005; 103:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarcatu D, Tamasdan C, Moryl N, Obbens E. Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia. J Opioid Manag 2007; 3:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jannuzzi RG. Nalbuphine for Treatment of Opioid-induced Pruritus: A Systematic Review of Literature. Clin J Pain 2016; 32:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayhurst CJ, Durieux ME. Differential Opioid Tolerance and Opioid-induced Hyperalgesia: A Clinical Reality. Anesthesiology 2016; 124:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee M, Silverman SM, Hansen H, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011; 14:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramasubbu C, Gupta A. Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence. J Pain Palliat Care Pharmacother 2011; 25:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber L, Yeomans DC, Tzabazis A. Opioid-induced hyperalgesia in clinical anesthesia practice: what has remained from theoretical concepts and experimental studies? Curr Opin Anaesthesiol 2017; 30:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu EH, Tran DH, Lam SW, Irwin MG. Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain? Anaesthesia 2016; 71:1347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angst MS. Intraoperative Use of Remifentanil for TIVA: Postoperative Pain, Acute Tolerance, and Opioid-Induced Hyperalgesia. J Cardiothorac Vasc Anesth 2015; 29 Suppl 1:S16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martyn JAJ, Mao J, Bittner EA. Opioid Tolerance in Critical Illness. N Engl J Med 2019; 380:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larach DB, Hah JM, Brummett CM. Perioperative Opioids, the Opioid Crisis, and the Anesthesiologist. Anesthesiology 2022; 136:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kharasch ED, Brunt LM. Perioperative Opioids and Public Health. Anesthesiology 2016; 124:960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hah JM, Bateman BT, Ratliff J, et al. Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic. Anesth Analg 2017; 125:1733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah N, Sinha A, Thompson A, et al. An Automated Software Application Reduces Controlled Substance Discrepancies in Perioperative Areas. Anesthesiology 2019; 131:1264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller TE, Thacker JK, White WD, et al. Reduced length of hospital stay in colorectal surgery after implementation of an enhanced recovery protocol. Anesth Analg 2014; 118:1052.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eskicioglu C, Forbes SS, Aarts MA, et al. Enhanced recovery after surgery (ERAS) programs for patients having colorectal surgery: a meta-analysis of randomized trials. J Gastrointest Surg 2009; 13:2321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varadhan KK, Lobo DN, Ljungqvist O. Enhanced recovery after surgery: the future of improving surgical care. Crit Care Clin 2010; 26:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feldheiser A, Aziz O, Baldini G, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand 2016; 60:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandal D, Keller MS, Lee C, et al. Impact of Enhanced Recovery After Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge From the Hospital: A Historical-Prospective Study. Anesth Analg 2017; 125:1784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar K, Kirksey MA, Duong S, Wu CL. A Review of Opioid-Sparing Modalities in Perioperative Pain Management: Methods to Decrease Opioid Use Postoperatively. Anesth Analg 2017; 125:1749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg 2017; 152:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitrovic I, Margeta-Mitrovic M, Bader S, et al. Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences. Proc Natl Acad Sci U S A 2003; 100:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Kock M, Crochet B, Morimont C, Scholtes JL. Intravenous or epidural clonidine for intra- and postoperative analgesia. Anesthesiology 1993; 79:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lodenius Å, Maddison KJ, Lawther BK, et al. Upper Airway Collapsibility during Dexmedetomidine and Propofol Sedation in Healthy Volunteers: A Nonblinded Randomized Crossover Study. Anesthesiology 2019; 131:962.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Demiri M, Antunes T, Fletcher D, Martinez V. Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis. Br J Anaesth 2019; 123:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gelineau AM, King MR, Ladha KS, et al. Intraoperative Esmolol as an Adjunct for Perioperative Opioid and Postoperative Pain Reduction: A Systematic Review, Meta-analysis, and Meta-regression. Anesth Analg 2018; 126:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liang DY, Shi X, Li X, et al. The beta2 adrenergic receptor regulates morphine tolerance and physical dependence. Behav Brain Res 2007; 181:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar S, Kundra P, Ramsamy K, Surendiran A. Pharmacogenetics of opioids: a narrative review. Anaesthesia 2019; 74:1456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Long DR, Lihn AL, Friedrich S, et al. Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in New England. Br J Anaesth 2018; 120:1090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002; 3:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao SZ, Chung F, Hanna DB, et al. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J Pain Symptom Manage 2004; 28:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007; 41:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oderda GM, Gan TJ, Johnson BH, Robinson SB. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother 2013; 27:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Overdyk FJ, Dowling O, Marino J, et al. Association of Opioids and Sedatives with Increased Risk of In-Hospital Cardiopulmonary Arrest from an Administrative Database. PLoS One 2016; 11:e0150214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albrecht E, Grape S, Frauenknecht J, et al. Low- versus high-dose intraoperative opioids: A systematic review with meta-analyses and trial sequential analyses. Acta Anaesthesiol Scand 2020; 64:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu CL, King AB, Geiger TM, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients. Anesth Analg 2019; 129:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulier JP. Is opioid-free general anesthesia for breast and gynecological surgery a viable option? Curr Opin Anaesthesiol 2019; 32:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mauermann E, Ruppen W, Bandschapp O. Different protocols used today to achieve total opioid-free general anesthesia without locoregional blocks. Best Pract Res Clin Anaesthesiol 2017; 31:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown EN, Pavone KJ, Naranjo M. Multimodal General Anesthesia: Theory and Practice. Anesth Analg 2018; 127:1246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soffin EM, Lee BH, Kumar KK, Wu CL. The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse. Br J Anaesth 2019; 122:e198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beloeil H, Albaladejo P, Sion A, et al. Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study. Br J Anaesth 2019; 122:e98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naik BI, Kuck K, Saager L, et al. Practice Patterns and Variability in Intraoperative Opioid Utilization: A Report From the Multicenter Perioperative Outcomes Group. Anesth Analg 2022; 134:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frauenknecht J, Kirkham KR, Jacot-Guillarmod A, Albrecht E. Analgesic impact of intra-operative opioids vs. opioid-free anaesthesia: a systematic review and meta-analysis. Anaesthesia 2019; 74:651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           King CA, Perez-Alvarez IM, Bartholomew AJ, et al. Opioid-free anesthesia for patients undergoing mastectomy: A matched comparison. Breast J 2020; 26:1742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lirk P, Rathmell JP. Opioid-free anaesthesia: Con: it is too early to adopt opioid-free anaesthesia today. Eur J Anaesthesiol 2019; 36:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shanthanna H, Ladha KS, Kehlet H, Joshi GP. Perioperative Opioid Administration. Anesthesiology 2021; 134:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chapman CR, Vierck CJ. The Transition of Acute Postoperative Pain to Chronic Pain: An Integrative Overview of Research on Mechanisms. J Pain 2017; 18:359.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beloeil H, Garot M, Lebuffe G, et al. Balanced Opioid-free Anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or Intermediate Noncardiac Surgery. Anesthesiology 2021; 134:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brinck EC, Tiippana E, Heesen M, et al. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev 2018; 12:CD012033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy GS, Avram MJ, Greenberg SB, et al. Perioperative Methadone and Ketamine for Postoperative Pain Control in Spinal Surgical Patients: A Randomized, Double-blind, Placebo-controlled Trial. Anesthesiology 2021; 134:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mujukian A, Truong A, Tran H, et al. A Standardized Multimodal Analgesia Protocol Reduces Perioperative Opioid Use in Minimally Invasive Colorectal Surgery. J Gastrointest Surg 2020; 24:2286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg 2007; 104:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mathiesen O, Møiniche S, Dahl JB. Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedure. BMC Anesthesiol 2007; 7:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verret M, Lauzier F, Zarychanski R, et al. Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-analysis. Anesthesiology 2020; 133:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young JC, Dasgupta N, Chidgey BA, et al. Day-of-Surgery Gabapentinoids and Prolonged Opioid Use: A Retrospective Cohort Study of Medicare Patients Using Electronic Health Records. Anesth Analg 2021; 133:1119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kent ML, Hurley RW, Oderda GM, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative-4 Joint Consensus Statement on Persistent Postoperative Opioid Use: Definition, Incidence, Risk Factors, and Health Care System Initiatives. Anesth Analg 2019; 129:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elkassabany NM, Mariano ER. Opioid-free anaesthesia - what would Inigo Montoya say? Anaesthesia 2019; 74:560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veyckemans F. Opioid-free anaesthesia: Still a debate? Eur J Anaesthesiol 2019; 36:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lavand'homme P. Opioid-free anaesthesia: Pro: damned if you don't use opioids during surgery. Eur J Anaesthesiol 2019; 36:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alexander JC, Patel B, Joshi GP. Perioperative use of opioids: Current controversies and concerns. Best Pract Res Clin Anaesthesiol 2019; 33:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Picard P, Tramèr MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg 2000; 90:963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prabhakar H, Singh GP, Ali Z, et al. Pharmacological and non-pharmacological interventions for reducing rocuronium bromide induced pain on injection in children and adults. Cochrane Database Syst Rev 2016; 2:CD009346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klemola UM, Mennander S, Saarnivaara L. Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol. Acta Anaesthesiol Scand 2000; 44:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouvet L, Stoian A, Rimmelé T, et al. Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol. Anaesthesia 2009; 64:719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trabold F, Casetta M, Duranteau J, et al. Propofol and remifentanil for intubation without muscle relaxant: the effect of the order of injection. Acta Anaesthesiol Scand 2004; 48:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta A, Nizamuddin J, Elmofty D, et al. Opioid Abuse or Dependence Increases 30-day Readmission Rates after Major Operating Room Procedures: A National Readmissions Database Study. Anesthesiology 2018; 128:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rishel CA, Angst MS, Sun EC. Preoperative Opioid Utilization Patterns and Postoperative Opioid Utilization: A Retrospective Cohort Study. Anesthesiology 2021; 135:1015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vadivelu N, Mitra S, Kaye AD, Urman RD. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best Pract Res Clin Anaesthesiol 2014; 28:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pulley DD. Preoperative Evaluation of the Patient with Substance Use Disorder and Perioperative Considerations. Anesthesiol Clin 2016; 34:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bryson EO. The perioperative management of patients maintained on medications used to manage opioid addiction. Curr Opin Anaesthesiol 2014; 27:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy GS, Szokol JW. Intraoperative Methadone in Surgical Patients: A Review of Clinical Investigations. Anesthesiology 2019; 131:678.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cammarano WB, Pittet JF, Weitz S, et al. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998; 26:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 2003; 35:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tompkins DA, Bigelow GE, Harrison JA, et al. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend 2009; 105:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stromer W, Michaeli K, Sandner-Kiesling A. Perioperative pain therapy in opioid abuse. Eur J Anaesthesiol 2013; 30:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang D, Yee BJ, Grunstein RR, Chung F. Chronic Opioid Use and Central Sleep Apnea, Where Are We Now and Where To Go? A State of the Art Review. Anesth Analg 2021; 132:1244.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 94536 Version 33.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1824743" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Pharmacokinetics, pharmacodynamics, and rational opioid selection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32773691" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Rational Perioperative Opioid Management in the Era of the Opioid Crisis: Comment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16871060" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18633028" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9778007" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The pharmacodynamic interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, and abdominal wall retraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7943832" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1389820" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9286884" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3257362" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The influence of fentanyl and tracheal intubation on the hemodynamic effects of anesthesia induction with propofol/N2O in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8873541" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Reduction of isoflurane minimal alveolar concentration by remifentanil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9278850" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Drug interactions: volatile anesthetics and opioids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12883407" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1363221" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31104756" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Are opioids indispensable for general anaesthesia?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6318605" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Fentanyl preloading for rapid-sequence induction of anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24660155" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Comparison between the effects of alfentanil, fentanyl and sufentanil on hemodynamic indices during rapid sequence intubation in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11270019" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Small doses of remifentanil or sufentanil for blunting cardiovascular changes induced by tracheal intubation: a double-blind comparison.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10365011" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7032347" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Treatment of stress response to laryngoscopy and intubation with fentanyl.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26919658" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The effect of titrated fentanyl on suppressed cough reflex in healthy adult volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23512191" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Conscious sedation for awake fibreoptic intubation: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22192640" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : TCI remifentanil vs. TCI propofol for awake fiber-optic intubation with limited topical anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19737187" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Guidelines for prevention of fentanyl-induced cough.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23958914" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Pharmacological and nonpharmacological prevention of fentanyl-induced cough: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19468616" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : [Effect of pretreatment with lidocaine, intravenous paracetamol and lidocaine-fentanyl on propofol injection pain. Comparative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17513655" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Multimodal analgesia to prevent propofol-induced pain: pretreatment with remifentanil and lidocaine versus remifentanil or lidocaine alone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17159759" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Prevention of pain on injection of propofol: a comparison of remifentanil with alfentanil in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23198034" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Single pretreatment of remifentanil may reduce pain after propofol and rocuronium injection in rapid sequence induction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30915997" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32249425" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Opioid-induced ventilatory impairment: current 'track and trigger' tools need to be updated.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16297754" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15169738" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17646499" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26287299" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Postoperative Hypoxemia Is Common and Persistent: A Prospective Blinded Observational Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27607476" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Long-Acting Patient-Controlled Opioids Are Not Associated With More Postoperative Hypoxemia Than Short-Acting Patient-Controlled Opioids After Noncardiac Surgery: A Cohort Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32925317" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Postoperative Opioid-Induced Respiratory Depression: 3 Steps Forward.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32925318" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Prediction of Opioid-Induced Respiratory Depression on Inpatient Wards Using Continuous Capnography and Oximetry: An International Prospective, Observational Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19690220" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19690220" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/943974" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Cardiovascular dynamics after large doses of fentanyl and fentanyl plus N2O in the dog.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6966530" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Haemodynamic and biochemical variables after induction of anaesthesia with fentanyl and nitrous oxide in patients undergoing coronary artery by-pass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9357922" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Severe bradycardia after remifentanil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23546488" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Fentanyl-induced chest wall rigidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2892437" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Rapid administration of a narcotic and neuromuscular blocker: a hemodynamic comparison of fentanyl, sufentanil, pancuronium, and vecuronium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24904804" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Are we anesthesiologists, aware about the incidence of muscle stiffness associated with remifentanil?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19702212" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : [Increased dose of remifentanil caused difficult ventilation at emergence from general anesthesia].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19702213" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : [Case of muscle rigidity by remifentanil just before the end of surgery].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24910942" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Efficacy and safety of remifentanil and sulfentanyl in painless gastroscopic examination: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25669008" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Impossible mask ventilation after an unusually low dose fentanyl-induced muscle rigidity in a patient with essential tremor: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12514147" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29712673" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : A 52-year-old man with fentanyl-induced muscle rigidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24356162" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Consensus guidelines for the management of postoperative nausea and vomiting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34237130" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Evaluation of Therapies for Peripheral and Neuraxial Opioid-induced Pruritus based on Molecular and Cellular Discoveries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15983470" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Primer of postoperative pruritus for anesthesiologists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18027543" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26650717" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Nalbuphine for Treatment of Opioid-induced Pruritus: A Systematic Review of Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26594912" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Differential Opioid Tolerance and Opioid-induced Hyperalgesia: A Clinical Reality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21412369" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : A comprehensive review of opioid-induced hyperalgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21834699" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28590258" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Opioid-induced hyperalgesia in clinical anesthesia practice: what has remained from theoretical concepts and experimental studies?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10910490" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27734470" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26025041" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Intraoperative Use of Remifentanil for TIVA: Postoperative Pain, Acute Tolerance, and Opioid-Induced Hyperalgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30673555" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Opioid Tolerance in Critical Illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35108351" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Perioperative Opioids, the Opioid Crisis, and the Anesthesiologist.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26808634" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Perioperative Opioids and Public Health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29049117" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31730551" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : An Automated Software Application Reduces Controlled Substance Discrepancies in Perioperative Areas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24781574" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Reduced length of hospital stay in colorectal surgery after implementation of an enhanced recovery protocol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19459015" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Enhanced recovery after surgery (ERAS) programs for patients having colorectal surgery: a meta-analysis of randomized trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20643305" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Enhanced recovery after surgery: the future of improving surgical care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26514824" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29049123" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Impact of Enhanced Recovery After Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge From the Hospital: A Historical-Prospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29049119" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : A Review of Opioid-Sparing Modalities in Perioperative Pain Management: Methods to Decrease Opioid Use Postoperatively.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28564673" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12496346" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8363078" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Intravenous or epidural clonidine for intra- and postoperative analgesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31403974" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Upper Airway Collapsibility during Dexmedetomidine and Propofol Sedation in Healthy Volunteers: A Nonblinded Randomized Crossover Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31623842" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Perioperative adverse events attributed toα2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29028742" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Intraoperative Esmolol as an Adjunct for Perioperative Opioid and Postoperative Pain Reduction: A Systematic Review, Meta-analysis, and Meta-regression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17498818" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : The beta2 adrenergic receptor regulates morphine tolerance and physical dependence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31454083" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Pharmacogenetics of opioids: a narrative review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29661386" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in New England.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14622770" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Adverse events associated with postoperative opioid analgesia: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15223083" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Dose-response relationship between opioid use and adverse effects after ambulatory surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17341537" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23302094" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Effect of opioid-related adverse events on outcomes in selected surgical patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26913753" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Association of Opioids and Sedatives with Increased Risk of In-Hospital Cardiopulmonary Arrest from an Administrative Database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31506922" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Low- versus high-dose intraoperative opioids: A systematic review with meta-analyses and trial sequential analyses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31082966" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31045633" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Is opioid-free general anesthesia for breast and gynecological surgery a viable option?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29739542" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Different protocols used today to achieve total opioid-free general anesthesia without locoregional blocks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30252709" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Multimodal General Anesthesia: Theory and Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30915988" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30915987" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34291737" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Practice Patterns and Variability in Intraoperative Opioid Utilization: A Report From the Multicenter Perioperative Outcomes Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30802933" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Analgesic impact of intra-operative opioids vs. opioid-free anaesthesia: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32767477" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Opioid-free anesthesia for patients undergoing mastectomy: A matched comparison.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30817360" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Opioid-free anaesthesia: Con: it is too early to adopt opioid-free anaesthesia today.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32991672" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Perioperative Opioid Administration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27908839" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : The Transition of Acute Postoperative Pain to Chronic Pain: An Integrative Overview of Research on Mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33630043" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Balanced Opioid-free Anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or Intermediate Noncardiac Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30570761" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Perioperative intravenous ketamine for acute postoperative pain in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33730151" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Perioperative Methadone and Ketamine for Postoperative Pain Control in Spinal Surgical Patients: A Randomized, Double-blind, Placebo-controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31515761" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : A Standardized Multimodal Analgesia Protocol Reduces Perioperative Opioid Use in Minimally Invasive Colorectal Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17513656" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17617920" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32667154" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34260433" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Day-of-Surgery Gabapentinoids and Prolonged Opioid Use: A Retrospective Cohort Study of Medicare Patients Using Electronic Health Records.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30897590" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : American Society for Enhanced Recovery and Perioperative Quality Initiative-4 Joint Consensus Statement on Persistent Postoperative Opioid Use: Definition, Incidence, Risk Factors, and Health Care System Initiatives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30802930" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Opioid-free anaesthesia - what would Inigo Montoya say?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30817358" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Opioid-free anaesthesia: Still a debate?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30817359" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Opioid-free anaesthesia: Pro: damned if you don't use opioids during surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31785719" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Perioperative use of opioids: Current controversies and concerns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10735808" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Prevention of pain on injection with propofol: a quantitative systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26871982" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Pharmacological and non-pharmacological interventions for reducing rocuronium bromide induced pain on injection in children and adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10757583" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19624626" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14674971" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Propofol and remifentanil for intubation without muscle relaxant: the effect of the order of injection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29470180" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Opioid Abuse or Dependence Increases 30-day Readmission Rates after Major Operating Room Procedures: A National Readmissions Database Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34731242" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Preoperative Opioid Utilization Patterns and Postoperative Opioid Utilization: A Retrospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24815969" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26927748" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Preoperative Evaluation of the Patient with Substance Use Disorder and Perioperative Considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24500338" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : The perioperative management of patients maintained on medications used to manage opioid addiction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31094758" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Intraoperative Methadone in Surgical Patients: A Review of Clinical Investigations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9559604" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12924748" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : The Clinical Opiate Withdrawal Scale (COWS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19647958" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23241915" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Perioperative pain therapy in opioid abuse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33857966" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Chronic Opioid Use and Central Sleep Apnea, Where Are We Now and Where To Go? A State of the Art Review.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
